Turner Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Turner Investments’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,104	Closed	-$302K	–	153
2017 Q2	$302K	Buy	+19,104	New	+$278K	0.2%	144
2016 Q1	–	Sell	-125,191	Closed	-$1.22M	–	233
2015 Q4	$1.22M	Hold	125,191	–	–	0.25%	122
2015 Q3	$1.09M	Buy	+125,191	New	+$1.17M	0.22%	133
2014 Q3	–	Sell	-916,598	Closed	-$11.8M	–	544
2014 Q2	$11.8M	Sell	916,598 -428,789	-32%	-$4.66M	0.52%	36
2014 Q1	$13.9M	Buy	1,345,387 +190,096	+16%	+$2.14M	0.37%	76
2013 Q4	$11.2M	Buy	+1,155,291	New	+$10.4M	0.2%	162
2013 Q3	–	Sell	-110,708	Closed	-$920K	–	630
2013 Q2	$920K	Buy	+110,708	New	+$1.34M	0.01%	499

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Turner Investments's IRWD Position: Q3 2017 in Review

Turner Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2017, closing a stake of 19,104 shares — an estimated $302K sold.

Turner Investments first reported a position in IRWD in Q2 2013 and held it in 7 quarters. The position peaked at $13.9M in Q1 2014. 149 funds tracked by Wall St. Rank hold IRWD as of Q3 2017.

Turner Investments reported no remaining Ironwood Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Turner Investments sold 19,104 Ironwood Pharmaceuticals shares in Q3 2017, an estimated $302K.
Turner Investments first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Turner Investments's Ironwood Pharmaceuticals position peaked at $13.9M in Q1 2014.
149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.